Factors associated with the control of severe asthma
- PMID: 20170317
- DOI: 10.3109/02770900903518835
Factors associated with the control of severe asthma
Abstract
Introduction: Control is a priority treatment objective in asthma, and classification based on control is recommended in the follow-up of asthmatic patients. Different factors affect this control, and there are several regional differences, both in terms of prevalence and in terms of management and degree of control.
Objective: To evaluate the factors associated with control of severe asthma in routine clinical practice.
Material and methods: This was a prospective, cross-sectional, observational study of patients with severe asthma who were receiving treatment with a fixed combination of a corticosteroid (at least 800 microg/day of budesonide or equivalent) and an inhaled beta(2)-adrenergic agonist in respiratory medicine and allergology clinics throughout Spain. The authors collected demographic and socioeconomic data, as well as clinical data on asthma. The patients also completed a self-administered validated questionnaire-the Asthma Control Questionnaire (ACQ)-about the control of their asthma.
Results: The authors included 1471 patients, of whom 1224 (83%) were valid for the final analysis. Women accounted for 61%. Mean age was 51 +/- 16 years. The mean number of exacerbations during the previous year was 2.0 +/- 2.0. The global score on the ACQ was 1.8 +/- 1.1 (0 = no symptoms; 6 = maximum number of symptoms). Only 20.4% of patients were well controlled (ACQ < 0.75), and 55.7% of patients were poorly controlled (ACQ > 1.5). The multivariate analysis revealed that the variable with the greatest effect on control of asthma was the number of exacerbations during the previous year: when the number of exacerbations increased from 0 to 1 or more, the ACQ score increased by 0.56 points. Employed patients had a mean of 0.23 points less (better control) than unemployed and retired patients. Control of asthma was also significantly affected by adherence to treatment, patient knowledge of the disease, body mass index, gender, and number of visits to a physician in the previous 3 months.
Conclusions: Many patients with severe asthma have poor control of their disease. The number of exacerbations is the variable with the greatest effect on control of asthma. Knowledge of the disease and adherence to treatment are associated with better control.
Similar articles
-
Control of persistent asthma in Spain: associated factors.J Asthma. 2008 Nov;45(9):740-6. doi: 10.1080/02770900802216783. J Asthma. 2008. PMID: 18972288
-
The impact of alexithymia on asthma patient management and communication with health care providers: a pilot study.J Asthma. 2009 Mar;46(2):126-9. doi: 10.1080/02770900802468525. J Asthma. 2009. PMID: 19253116
-
Factors associated with asthma control.J Asthma. 2005 Oct;42(8):659-65. doi: 10.1080/02770900500264903. J Asthma. 2005. PMID: 16266957
-
[Asthma control. Possible obstacles along the way].Arch Bronconeumol. 2010 Oct;46 Suppl 6:8-13. doi: 10.1016/S0300-2896(10)70037-5. Arch Bronconeumol. 2010. PMID: 21316543 Review. Spanish.
-
Women with asthma: a review of potential variables and preferred medical management.Ann Allergy Asthma Immunol. 2006 May;96(5):655-65. doi: 10.1016/S1081-1206(10)61062-9. Ann Allergy Asthma Immunol. 2006. PMID: 16729777 Review.
Cited by
-
House dust mite allergy in Malaysia: review of research gaps in the current scenario and the way forward.Exp Appl Acarol. 2023 Dec;91(4):509-539. doi: 10.1007/s10493-023-00857-5. Epub 2023 Nov 23. Exp Appl Acarol. 2023. PMID: 37995026 Review.
-
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma.ERJ Open Res. 2020 Jan 27;6(1):00204-2019. doi: 10.1183/23120541.00204-2019. eCollection 2020 Jan. ERJ Open Res. 2020. PMID: 32010719 Free PMC article.
-
Describing the burden of moderate exacerbations in patients with asthma from the Extended Salford Lung Study (Ext-SLS): a retrospective cohort study.Respir Res. 2025 Mar 29;26(1):121. doi: 10.1186/s12931-025-03199-5. Respir Res. 2025. PMID: 40158113 Free PMC article.
-
Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review.Int J Mol Sci. 2020 Jan 30;21(3):889. doi: 10.3390/ijms21030889. Int J Mol Sci. 2020. PMID: 32019141 Free PMC article.
-
[Asthma 2020 Nursing Consensus Document].Open Respir Arch. 2021 Jan 8;3(1):100079. doi: 10.1016/j.opresp.2020.100079. eCollection 2021 Jan-Mar. Open Respir Arch. 2021. PMID: 37497358 Free PMC article. Spanish.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical